SCHEMBL1084235

SCHEMBL1084235

CN(C)c1nc(-c2ccccc2N2CCCCC2)nc2ccc(Cl)cc12

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.51
HRH4 Q9H3N8 1/20 0.51
PDE10A Q9Y233 7/20 0.50
CYP2D6 P10635 5/20 0.43
CYP1A2 P05177 4/20 0.43
TSHR P16473 3/20 0.43
CLK4 Q9HAZ1 2/20 0.43
MAPK1 P28482 1/20 0.43
CYP2C19 P33261 1/20 0.43
ABCB1 P08183 1/20 0.43
FABP3 P05413 2/20 0.42
FABP4 P15090 2/20 0.42
FABP5 Q01469 2/20 0.42
ALDH1A1 P00352 2/20 0.41
USP2 O75604 1/20 0.41
LMNA P02545 1/20 0.41
TP53 P04637 1/20 0.41
CYP3A4 P08684 1/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1084143 0.99 HTR3A (0.52) HTR3AHRH4PDE10ACYP2D6CYP1A2
SCHEMBL1084177 0.90 HRH4 (0.65) HTR3AHRH4PDE10ACYP2D6CYP1A2
SCHEMBL1084304 0.86 CYP2D6 (0.59) CYP2D6CYP1A2TSHRCLK4MAPK1
SCHEMBL1083873 0.85 CYP2D6 (0.60) CYP2D6CYP1A2TSHRCLK4MAPK1
SCHEMBL1084156 0.84 PDE10A (0.54) HTR3AHRH4PDE10ACYP2D6CYP1A2
SCHEMBL1083797 0.78 CYP1A2 (0.51) HTR3AHRH4PDE10ACYP2D6CYP1A2
SCHEMBL1084188 0.77 CYP1A2 (0.50) HTR3AHRH4PDE10ACYP2D6CYP1A2
SCHEMBL1084198 0.75 CYP1A2 (0.48) HTR3AHRH4PDE10ACYP2D6CYP1A2
SCHEMBL1084306 0.75 CYP2D6 (0.58) HTR3ACYP2D6CYP1A2TSHRCLK4
SCHEMBL1084294 0.72 HIF1A (0.51) HTR3AHRH4CYP2D6CYP1A2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8343980-B2 Quinazoles useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2013-01-01 US disclosed
US-8153642-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2012-04-10 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7713983-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-05-11 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed
US-7678802-B2 Quinazolines useful as modulators of ion channels VERTEX PHARMACEUTICALS INCORPORATED (US) 2010-03-16 US disclosed